NUVB

Nuvation Bio Inc

• NASDAQ·09/03 13:55

  Does Nuvation Bio (NUVB) Have the Potential to Rally 91.92% as Wall Street Analysts Expect?

• PR Newswire·09/02 20:05

  Nuvation Bio to Participate in Upcoming Investor Conferences

• Seeking Alpha·08/26 20:15

  Nuvation: Why I'm Downgrading To Hold Despite Progress On NSCLC And Glioma Fronts

• Seeking Alpha·08/22 21:57

  SA Asks: What are the most promising oncology companies right now?

• Seeking Alpha·08/21 15:10

  Nuvation Bio rises as Cantor initiates at overweight

• TipRanks·08/21 10:10

  Nuvation Bio initiated with an Overweight at Cantor Fitzgerald

• NASDAQ·08/21 07:44

  Nuvation Bio Secures FDA Fast Track For Safusidenib In IDH1- Mutant Glioma

• Seeking Alpha·08/20 13:00

  Nuvation granted Fast Track status for safusidenib for brain tumors

• Dow Jones·08/20 12:38

  Nuvation Bio Granted FDA Fast-Track Designation for Glioma Treatment

• Seeking Alpha·08/18 16:06

  Nuvation wins new Overweight at J.P. Morgan on launch trajectory for lead drug

• NASDAQ·08/18 13:55

  Wall Street Analysts Predict a 105.71% Upside in Nuvation Bio (NUVB): Here's What You Should Know

• Dow Jones·08/18 12:33

  Nuvation Bio Initiated at Overweight by JP Morgan

• Dow Jones·08/18 12:33

  Nuvation Bio Price Target Announced at $13.00/Share by JP Morgan

• TipRanks·08/18 08:55

  Nuvation Bio initiated with an Overweight at JPMorgan

• Seeking Alpha·08/14 00:42

  Tracking David Abrams' Abrams Capital Management Portfolio - Q2 2026 Update